AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

CDMO Recipharm continues its rapid expansion with a second fill-finish facility, this time in India

Lumen plots site at nearby Seattle bakery as it ramps up production of algae-based biologics

Meet the new GSK consumer health boss after spinoff, same as the old boss despite Elliott's threat for change

Takeda lays out $126M to tap robotics, virtual reality and more at California production site